FAQ

broussoflavonol B

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
01220132015

Related topics

Related topics

1 relation

Broader (1)

Flavonols

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
broussoflavonol B
Flavonols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen.
Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, HER2 overexpressing breast… (More)
Is this relevant?
2014
2014
Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, most breast tumors develop… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells.
Accumulating experimental and clinical evidence has indicated that tumor-initiating or cancer stem-like cells are a sub… (More)
Is this relevant?
2013
2013
A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.
Estrogen receptor (ER)-negative breast cancers are aggressive and unresponsive to antiestrogens, and current therapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?